Beltsville, MD; and Hyderbad, AP, India, October 21, 2009 – BioServe™, a leading provider of clinical bio-samples and research services, today announced that it has been selected by the Government of the State of Andhra Pradesh in India and The Institute of Preventive Medicine (IPM) Hyderabad as one of two private diagnostic centers to test samples of Influenza A – H1N1 (Swine Flu) in afflicted patients. BioServe’s ISO 9001:2008 and ISO 17025:2005 (NABL) certified genomic laboratory in Hyderabad, India is one of the most advanced full-service reference laboratories in the country.
In addition, to help prepare the Indian health system for a robust response to pandemic outbreaks of swine flu, BioServe is also developing a powerful one-step PCR diagnostic test for effective identification of swine flu, at a price point that makes it possible to carry out mass screenings of large populations in India. The test will be certified in accordance with the prevailing guidelines for diagnosis of virus strains, and is scheduled for a market launch upon due validation and verification.
According to the Indian Government’s most recent data, there have been 12,880 confirmed cases of swine flu and 415 deaths from the virus. The country’s Ministry of Health views the addition of BioServe’s new diagnostic center as critical to expediting the testing of swine flu samples, which will enable the authorities to diagnose more cases and start treatment immediately, thus mitigating the risks of spreading the disease further throughout the population.
Rama Modali, President, BioServe, said, “We are proud to be a key part in India’s fight against the pandemic outbreaks of swine flu. BioServe’s clinical testing labs, as well as our indigenous swine flu diagnostic test currently in development, will help provide the rapid and accurate diagnoses that are critical to disease containment and treatment in India and countries around the world.”